(1), numerous hypotheses have been advancedl to explain the pathogenesis of leukopenia. These hiave included increased splenic sequestration (2) , excessive margin-ation of leukocytes with concomitant increased peripheral destruction (3), leukocyte-specific antibodies present in serum (4) , and neutrophilbound IgG (5) . Defective myelopoiesis has also beeni founid in Felty's Syncdrome (FS) and thought to be due to a maturation arrest of the granulocytic series (6) secondary to inihibitory serum factors (7) or lack of myelopoiesis stimnulatinlg factors (8) .
Thymus-dependent (T) lymphocytes represent a heterogeneous group of cells that have various funetions (9) . Subpopulations of T cells, called regulator or suppressor cells, have been shown to inhibit various immune parameters (10) . Hyperactive suppressor cells have been implicated in the pathogenesis of the decreased immunoglobulin (Ig) synthesis in some patients with common variable hypogammiinzaglobulinemia (11) , the decreased levels of n1on1-paraprotein Ig in mnultiple myeloma (12) , the failure of hematopoiesis in some patients with idiopathic aplastic anemia (13) , the decreased erythropoiesis in Diamond-Blackfan Syndrome (14) , and in the anergyaccompanying systemic fungal infections (15) . On the other hand, defective suppressor cell function has been shown by us to be present and possibly responsible for the emergence of autoreactive clones in active systemic lupus erythematosus (16) . There are no published reports on the role of suppressor cells in defective myelopoiesis.
The possibility of lymphocyte-mediated suppression of myelopoiesis has prompted us to examine the neutropenia of FS for the possible role of suppressor cells at the level of the myeloid precursor cell. In this report we have used the granulocyte colonyforming unit assay in culture (CFU-C) and demonstrated the presence of mononuclear suppressor cells Table I . One patient had splenectoiny 4 yr before the study and a second patient was studied presplenectomy and 3 wk and 21 wk postsplenectomy. Four patients had inactive arthritis and three were on no drugs. Two of the patients had received blood transfusions in the past and two of the three females in the study had two nonral pregnancies each.
Three patients had neutropenia < 1,000/mmn3 at the time ofthe study. All patients had normal monocyte and platelet counts, slight anemia (hemoglobin 10.5-13.2 g/100 ml), normal serum complement (CH50 and C3) and positive antinuclear antibodies (titer 1:40-1:640). Controls for the FS patients were six patients with RA without neutropenia or splenomegaly who were age and sex matched to the FS patients, and three patients with solid tumors under chemotherapy who had neutropenia without RA or splenomegaly. Another group of controls was 10 normal healthy voltunteers different from the "normal" bone marrow donors.
Consent forms were obtained from all patients and the study was approved by the Institution Human Experimentation Committee.
Evaluation of suppressor cells. Peripheral blood or bone marrow mononuclear cells were prepared by using the Ficoll-Hypaque technique (16) and from these were prepared enriched T, bone-marrow derived (B), and monocyte-depleted populations (16) (17) (18) . Enrichedl T cells were obtained by passage of mononuclear cells through Ig-anti-Ig glass bead columns (18) . This yielded cell suspensions containing more than 90% T cells as tested by the E-rosette method (18) . Enriched B cells were obtained by the E-rosette centrifugation method (16) . This yielded suspensions containing more than 83% B cells as tested by staining the cells with fluorescinated anti-Ig (18) . Monocytes were depleted by incubating cells with iron filings (Dow Chemical Co., Midland, Mich.) at 37°C for 30 iiin followed by passage of cells through a polyethylene tube wrapped around a magniet. This yielde(d <2% monocyte contamination as tested by the nonspecific esterase stain (18) . Splenic cell suspensions were prepared by mincing splenic fragments gently and forcing cells through a wire mesh as described by us for other organs (17) .
The CFU-C assay was performedl by plating 2.5 x 105 bone marrow cells per tissue culture plate (Falcon Plastics no. 3002, Oxnard, Calif.). The cells were mixed in 0.5 ml of 0.6% agar (Bacto agar, Difco Laboratories, Detroit, Nlich.), 0.1 ml fetal calf serum (Flow Laboratories, Inc., Rockville, Md.), and( 0.4 ml alpha medium (Flow Laboratories, Inc.). No colonvstimulating factors were usecl in these experimenits. The plates were prepared in triplicate and incubatedl at 37°C in a humid atmosphere of 5% CO2 in air. Colonies with greater than 50 cells were counted by the invertedl miciroseope. Cell aggregates of less than 50 cells were counted as clusters. Since the latter varied to a considerable degree between different experiments from the same donor, we didl not record them in the Results section. Cultures from the FS patients were studied at least twice and the mean number of CFU-C from triplicate culture plates were obtained. In all the experiment.s, "normal" bone marrow was usedl and( conisiste(d of aspirates fromn patients who hadl no neutropenia, auitoimmuniie disease, or malignancy. The effect of coculturinig 2.5 x 10`allogeneic normal or 2.5 x 10( FS mononuclear cells or 0.1 ml plasmiia with 2.5 x 105 normiial bone marrow was tested. The percenitage of CFU-C formeld was expressed by the following formulla: % CFU-C = (2.5 x 105 bone marrow + 2.5 x 105 patient's cells/2.5 x 105 bone marrow + 2.5 x 1(5 normilal's cells) x 100. The percentage of suppression of CFU-C was calculated by the formula: 100 -N CFU-C. The CFU-C capacity of FS or nornmal mononuclear cells was also tested in the ab)sence of the allogeneic normal bone marrow.
We performed several experimenits to (letermnine the optimal number of mon-onuclear cells capable of ind(lucing maximal suppression and founcl that e(qual numiibers of imononucelear ani(l mlarrow cells were optimal. In the cocuiltures the cell density in the culture was kept constanit at 5 x 105 cells/ plate. In all the experiments described, we have cocuiltured 2.5 x 10) bone imarrow cells with 2.5 x 10(5 Imlononluclear cells. Plasma fromi the controls or FS in various (loses, 0.05-0.5 ml, was also adde(d to the niormal bone marrow to test their suppressive and(or) enhancinig capacity. We founcl no significant differences between the various plasmia (loses. Therefore, we usedl 0.1 ml plasmiia in all the experiments described in the results sectioni.
Statistical analvsis was performiie(d with Stud(lent's t test. Table II shows the CFU-C numbers and percentage of normals formedl upoIn coculturin-g 2.5 x 104 normial bone marrow cells with eqiual numbers of blood monionuclear cells fromi FS and controls. When the blood neutrophil count of FS was below 1,000/mm3, there was significant suppression of CFU-C (P < 0.02). The three Felty's patients gave the following niumbers of CFU-C and percentage of normals: 6, 14%; 19, 31%; and 28, 39%. No significant suppression of CFU-C occurred when blood mononuclear cells were obtained from the 10 normal controls, FS with neutrophil counts >1,000/mm3, RA patients with normal neutrophil counts, or patients with imalignancy and neutropenia (Table II) . Table III shows the cell type responsible for suppression. T-cell eniriched preparations were the miost efficient in inducinig suppressioni (P < 0.01). Moonocytes also contributed to the suppressioni of CFU-C (P < 0.05). Depletion of monocytes from the B-cell preparation abolishedl the suppressive ability of the Bcell preparationi. The T-and B-cell preparations were >91% and >83% pure cell subpopulations, respectively. Contamiinating cells in the T preparations were <4% B cells and <1% monocytes and in the B preparations were 12+4% monocytes and <3% neutrophils. Plasma from the various FS patients at a dose of 0.1 nil/culture plate were not inhibitory to normnal CFU-C (Table III) . Increasing the plasma dose to 0.5 ml/plate or decreasing the (lose to 0.05 mnl/plate didl not significanitly change the value of suppressioni (not shown in Table III) . Table IV shows the suppressor capacity of cells obtained from the various lymphoid compartments. It Table IV that the numbers of CFU-C formed upon culturing FS marrow by itself were few when compared to normals. Table V shows the sequential studies of suppressor capacity of blood mononuclear cells of one FS patient before, and 3 and 21 wk after splenectomy. It can be seen that 3 wk after splenectomy the suppressive capacity of blood cells is no longer present. However, 21 wk postsplenectomy, there is evidence of suppression. The suppressive capacity roughly correlates with the absolute numbers of blood neutrophils.
RESULTS

In our initial experiments in which various
DISCUSSION
The present study suggests that cells from patients with FS can suppress normal granulopoiesis in bonie marrow cultures. These suppressor cells are predominantly T lymphocytes. Monocytes were also capable of inducing suppression. Spleniic cells possess Previous stu(Iies of the imiechaniismi of neutropenlia in FS have been contradictory (3-7) anid focused on humoral factors, primarily antibodies to leukocytes. Recently, there has been increasinig evidence that T cells play a role in RA. Anl increased number of T lymiiphocytes in synovial fluii(d (19) anid synovial tissue (20) of patients with RA and( in the peripheral blood of patients with FS (21) has been described. Moreover, bone marrow studlies in FS patients have demonstrated hyperplasia of lymphoid andl imonocytoid imononuclear cells (22) . Remiioval of T lymiphocytes from patients with rheumiatoidl arthritis by thoracic duct drainage has been shown to decrease disease activity (23).
Our results support those of others (3, 7, 8) in which (lecreased granulopoiesis in vitro in FS was shown. Our results show this suppression to be by a cellular and not by a serumii mechaniismii. Our results (lo not exclude the possibility that neutropenia may be due, in somie cases, to IgG bound to mature neutrophils as has receintly been (lemiionstrated by Logue (5) . The factors inducinig the suppressor cell activity in FS and the mechanismii by which suppression of granulopoiesis is me(liated are unknown at the present timie. Small mnolecuilar weight-soluble factors produced by T cells which are capable of inducing suppression in vitro have been described in other systems (24) . We doubt that the in vitro suppression of granulopoiesis (lelmonstrated in our study is (lue to alloiimmunizationi since suppression was shown by cells fromn one patienit who was nulliparous and did not receive transfusions. The target of suppressor cells was not identified in this study since our CFU-C assay was done in the absence of adlded colony-stimulating factor or feeder layers. The suppressor activity might be directedl at the cells which release colony-stimulating factor or at the myeloid precursor cells, thus preventinig in vitro differentiation into mature granulocytes.
The suppressor effect of the spleen has been shown in the single patient who had a splenectomy. Splenectomy in FS has a temporary beneficial effect on neutrophil counts which muay be due to removal of the bulk of suppressor cells. In miice (25, 26) and man (27) the spleen has been shown to be the principal organ in which suppressor cells reside. In man bone marrow T cells were shown by us to have greater suppressor activity than blood T cells (18, 28) . The recurrence of neutropenia several weeks after splenectomy may be due to activation of suppressor cells present in other organs suclh as bone marrow. Our findings therefore, may offer an explanation for the transient beneficial effects of splenectomy (29, 30) . It is apparent that other therapeutic modalities aimed at modulating the hyperactive suppressor cells are needed. The administration of antithymocyte globulini to a patient who suffered fromn aplastic anemiiia due to hyperactive suppressor T cells was effective in the partial correction of pancytopenia (28) . More work is needed to characterize the surface miarkers of suppressor cells, the mechanismn by which they mediate suppression andI the factor(s) that are responsible for the suppressor cell activation in vivo. The possibility that activation of suppressor cells imiay follow andl niot precede neutropenia should also be carefuilly considered.
